Inherited defects in checkpoint kinase 2 (CHEK2) to confer increased susceptibility to testicular germ cell tumors.

被引：1
|
作者：
Aldubayan, Saud H.
Pyle, Louisa T.
Loud, Jennifer T.
Greene, Mark H.
Sweeney, Christopher
Nathanson, Katherine
Van Allen, Eliezer Mendel
Stewart, Douglas R.
Lessel, Davor
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] NCI, Rockville, MD USA
[4] NCI, NIH, Rockville, MD USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1515
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors
    AlDubayan, Saud H.
    Pyle, Louise C.
    Gamulin, Marija
    Kulis, Tomislav
    Moore, Nathanael D.
    Taylor-Weiner, Amaro
    Hamid, Anis A.
    Reardon, Brendan
    Wubbenhorst, Bradley
    Godse, Rama
    Vaughn, David J.
    Jacobs, Linda A.
    Meien, Stefanie
    Grgic, Mislav
    Kastelan, Zeljko
    Markt, Sarah C.
    Damrauer, Scott M.
    Rader, Daniel J.
    Kember, Rachel L.
    Loud, Jennifer T.
    Kanetsky, Peter A.
    Greene, Mark H.
    Sweeney, Christopher J.
    Kubisch, Christian
    Nathanson, Katherine L.
    Van Allen, Eliezer M.
    Stewart, Douglas R.
    Lessel, Davor
    Van Hout, Cristopher
    O'Dushlaine, Colm
    Li, Alexander
    McCarthy, Shane
    Marcketta, Anthony
    Ye, Bin
    Dostal, Tanya Teslovich
    Schurmann, Claudia
    Gurski, Lauren
    Sun, Dylan
    Liu, Daren
    Abecasis, Goncalo
    Marchini, Jonathan
    Reid, Jeffrey
    Ulloa, Ricardo
    Habegger, Lukas
    Penn, John
    Bai, Xiaodong
    Hahn, Young
    Staples, Jeffrey
    Maxwell, Evan
    Manoochehri, Kia
    JAMA ONCOLOGY, 2019, 5 (04) : 514 - 522
  • [2] Evaluating pathogenic germline variants in checkpoint kinase 2 (CHEK2) in ovarian germ cell tumors
    Camp, Sabrina Yvonne
    Han, Seunghun
    AlDubayan, Saud H.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors
    Kirchner, Kira
    Seidel, Christoph
    Paulsen, Finn-Ole
    Sievers, Bianca
    Bokemeyer, Carsten
    Lessel, Davor
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [4] The CHEK2 gene and inherited breast cancer susceptibility
    Nevanlinna, H.
    Bartek, J.
    ONCOGENE, 2006, 25 (43) : 5912 - 5919
  • [5] The CHEK2 gene and inherited breast cancer susceptibility
    H Nevanlinna
    J Bartek
    Oncogene, 2006, 25 : 5912 - 5919
  • [6] In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
    Kim, S.
    Mohapatra, G.
    Haber, D. A.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1302 - 1306
  • [7] In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
    S Kim
    G Mohapatra
    D A Haber
    British Journal of Cancer, 2008, 99 : 1302 - 1306
  • [8] Checkpoint Kinase 2 (CHEK2) Mutation in Renal Cell Carcinoma: A Single-Center Experience
    Huszno, Joanna
    Kolosza, Zofia
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (01): : 19 - 23
  • [9] CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report
    Szeliga, Anna
    Pralat, Aleksandra
    Witczak, Wiktoria
    Podfigurna, Agnieszka
    Wojtyla, Cezary
    Kostrzak, Anna
    Meczekalski, Blazej
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (12) : 1 - 8
  • [10] TP53 and CHEK2 germline mutations in malignant solid tumors.
    Zhang, Zhiye
    Wu, Yaqing
    Luo, Ningning
    Zhang, Qin
    Han, Tiantian
    Bu, Xuesong
    Shuai, Qin
    Qi, Yingxue
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345